ArticlePharmaceutics2019

Combined Modality Therapy Based on Hybrid Gold Nanostars Coated with Temperature Sensitive Liposomes to Overcome Paclitaxel-Resistance in Hepatic Carcinoma.

Hongyan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.